The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.

Gelijkaardige items

• N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.
  door: Fischer, P B, et al.
  Gepubliceerd in: (1996)
• N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure.
  door: Fischer, P B, et al.
  Gepubliceerd in: (1996)
• Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin
  door: Jeyakumar, Mylvaganam, et al.
  Gepubliceerd in: (1999)
• Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin.
  door: Block, T M, et al.
  Gepubliceerd in: (1994)
• Characterization of the human lysosomal alpha-glucosidase gene.
  door: Hoefsloot, L H, et al.
  Gepubliceerd in: (1990)